 Clinical experience doxazosin general medical practice Netherlands study efficacy toleration once-daily doxazosin treatment essential hypertension diastolic blood pressure mm Hg general medical practice Fifty-three patients mild moderate essential hypertension study weeks duration baseline run-in period weeks dose-adjustment phase doxazosin weeks maintenance phase weeks Doxazosin mg/day weeks dose blood pressure diastolic blood pressure equal mm Hg equal mm Hg reduction baseline significant side effects maximum daily dose Doxazosin significant final mean change blood pressure Hg final mean daily dose Heart rate nonsignificant decrease total cholesterol concentration triglycerides effect doxazosin blood pressure serum cholesterol significant reduction calculated risk coronary heart disease investigators assessment patient toleration doxazosin excellent good patients